COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,950 Articles (22,604 medRxiv, 8,346 bioRxiv)

Most recent first Previous |  Page 1118: Articles 11171-11180  | Next

Clinically observed deletions in SARS-CoV-2 Nsp1 affect protein stability and its ability to inhibit translation
Kumar, P., Schexnaydre, E., Rafie, K., Terenin, I., Hauryliuk, V., Carlson, L.-A.
10.1101/2021.11.03.467065 — Posted: 2021-11-04
Spatialized Epidemiological Forecasting applied to Covid-19 Pandemic at Departmental Scale in France
OLIVER, M., GEORGES, D., PRIEUR, C.
10.1101/2021.11.03.21265855 — Posted: 2021-11-04
Prevalence of Antibodies to SARS-CoV-2 following natural infection and vaccination in Irish Hospital Healthcare Workers; changing epidemiology as the pandemic progresses
allen, n., Brady, M., Ni Riain, U., Conlon, N., Domegan, L., Carrion Martin, I., Walsh, C., Doherty, L., Kerr, C., Higgins, E., Bergin, C., Fleming, C.
10.1101/2021.11.04.21265921 — Posted: 2021-11-04
Plasma markers of neurologic injury and systemic inflammation in individuals with self-reported neurologic post-acute sequelae of SARS-CoV-2 infection (PASC)
Peluso, M. J., Sans, H. M., Forman, C. A., Nylander, A. N., Ho, H.-e., Lu, S., Goldberg, S. A., Hoh, R., Tai, V., Munter, S. E., Chenna, A., Yee, B. C., Winslow, J. W., Petropoulos, C. J., Martin, J. N., Kelly, J. D., Durstenfeld, M. S., Hsue, P. Y., Hunt, P. W., Greene, M., Chow, F. C., Hellmuth, J., Henrich, T. J., Glidden, D. V., Deeks, S. G.
10.1101/2021.11.02.21265778 — Posted: 2021-11-04
How Do College Students with Disabilities Feel About Taking COVID-19 Vaccines?
Taylor, Z. W., Charran, C.
10.1101/2021.11.04.21265923 — Posted: 2021-11-04
Low selectivity index of ivermectin and macrocyclic lactones on SARS-CoV2 replication in vitro argues against their therapeutic use for COVID-19.
Chable-Bessia, C., Boulle, C., Neyret, A., Swain, J. M., Henaut, M., Merida, P., Gros, N., Makinson, A., Lyonnais, S., Chesnais, C. B., Muriaux, D.
10.1101/2021.11.01.466865 — Posted: 2021-11-04
REACT-1 round 15 interim report: High and rising prevalence of SARS-CoV-2 infection in England from end of September 2021 followed by a fall in late October 2021
Chadeau-Hyam, M., Eales, O., Bodinier, B., Wang, H., Haw, D. J., Whitaker, M., Walters, C. E., Atchison, C. J., Diggle, P. J., Page, A. J., Ashby, D., Barclay, W., Taylor, G. P., Cooke, G., Ward, H., Darzi, A., Donnelly, C. A., Elliott, P.
10.1101/2021.11.03.21265877 — Posted: 2021-11-03
The impact of the initial and 2nd national COVID-19 lockdown on mental health in young people with and without pre-existing depressive symptoms
Joensen, A., Danielsen, S., Andersen, P. K., Groot, J., Strandberg-Larsen, K.
10.1101/2021.11.03.21265861 — Posted: 2021-11-03
Investigating the relationship between interventions, contact patterns, and SARS-CoV-2 transmissibility
Trentini, F., Manna, A., Balbo, N., Marziano, V., Guzzetta, G., Merler, S., Ajelli, M., Poletti, P., Melegaro, A.
10.1101/2021.11.03.21265876 — Posted: 2021-11-03
Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
Hussain, T., Afsar, M., Narayan, R., Akhtar, M. N., Rahil, H., Eswarappa, S., Tripathi, S.
10.1101/2021.11.02.466951 — Posted: 2021-11-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).